Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Nonviolent Communication Plus Personalised E-message for Parents

14 de setembro de 2026 atualizado por: Dr Grace SUN Yuying, Hong Kong Metropolitan University

A Rolling Two-session Nonviolent Communication Intervention Plus Personalised E-message in Improving Child-parent Relationship: a Pilot Randomised Controlled Trial

This pilot randomised controlled trial (RCT) aims to evaluate the feasibility, acceptability, and preliminary effects of combining a brief Nonviolent Communication (NVC) intervention with follow-up personalised AI-generated messages delivered daily via WhatsApp to improve child-parent relationships, parenting competence and family communication.

A total of 60 parents of middle school students experiencing difficulties in family communication or recurrent conflict with their children will be recruited in Hong Kong and randomly assigned (in a 1:1 allocation ratio) to an intervention group or an attention control group.

The intervention group will participate in two 2-hour NVC workshops, scheduled two weeks apart and delivered by the principal investigator, plus four weeks of personalised AI-generated NVC e-messages daily. The attention control group will receive weekly e-messages with healthy lifestyle tips for 6 weeks.

Assessments for participants will be conducted at baseline (T0), post-workshop (T1, after the second session/two weeks after T0), and 12 weeks after baseline (T2). A process evaluation featuring quantitative ratings and open-ended questions will be conducted to explore participants' perceived benefits and subjective experiences.

Visão geral do estudo

Tipo de estudo

Intervencional

Inscrição (Estimado)

60

Estágio

  • Não aplicável

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Contato de estudo

  • Nome: Yuying Sun, PhD
  • Número de telefone: 852 39702916
  • E-mail: gsun@hkmu.edu.hk

Locais de estudo

      • Hong Kong, Hong Kong
        • The Jockey Club Institute of Healthcare, Hong Kong Metropolitan University
        • Contato:

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

  • Adulto

Aceita Voluntários Saudáveis

Não

Descrição

Inclusion Criteria:

  • 1) parents aged 32-59 years with children attending middle school (approximately 12-17 years old) in Hong Kong;
  • 2) scoring 3 or above in any item of the 3-item conflict subscale of the Network of Relationship Inventory (Furman & Buhrmester, 2009);
  • 3) able to read Chinese and use a smartphone to receive WhatsApp messages;
  • 4) willingness to attend a two-session NVC intervention in group format.

Exclusion Criteria:

  • 1) severe mental health problems requiring immediate specialist care or inability to provide informed consent.

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Prevenção
  • Alocação: Randomizado
  • Modelo Intervencional: Atribuição Paralela
  • Mascaramento: Nenhum (rótulo aberto)

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Experimental: NVC Intervention Group
Participants in the intervention group will receive two 2-hour NVC intervention workshops, scheduled two weeks apart and delivered in small groups (either online or face-to-face) by the PI, plus four weeks of daily personalised AI-generated NVC messages via WhatsApp.

The intervention includes an introduction to NVC's four principles, the difference between observations and judgments, identifying and expressing feelings, taking responsibility for feelings and needs, and using positive action language when making requests.

The intervention workshops will be offered in rolling monthly cycles for approximately three rounds over three months (two rounds will be online, and one will be face-to-face). Participants who miss the second session may attend an equivalent session in the second or third cycle. Between and following the sessions, participants will receive AI-generated, tailored messages via WhatsApp daily for four weeks that provide concise NVC tips and guide parents through NVC-style conversations with their adolescents.

Comparador Ativo: Attention Control Group
Participants in the attention control group will not receive any NVC intervention workshops during the study. They will receive regular healthy lifestyle information messages via WhatsApp for 6 weeks.
The attention control group will receive an information pamphlet that encourages them to maintain a healthy diet, engage in regular physical activity, and practice weight control. Participants will receive weekly WhatsApp messages about healthy lifestyle tips for 6 weeks.

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
Recruitment rate
Prazo: Baseline (T0)
Recruitment rate is defined as the proportion of eligible or contacted candidates who actually agree to join the study (Number Enrolled / Number Eligible or Approached).
Baseline (T0)
Retention rate
Prazo: 12-week assessment (T2, around 3 months after baseline)
Retention rate is defined as the percentage of randomised participants retained and assessed with valid primary outcome data.
12-week assessment (T2, around 3 months after baseline)

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
Child-Parent Relationship
Prazo: Baseline (T0), Post-workshop assessment (T1, 2 weeks after T0), and 12-week assessment (T2, around 3 months after T0).
The Child-Parent Relationship Scale (CPRS-SF) is a 15-item scale for evaluating two dimensions of the relationship between parents and children: conflict and closeness. Items are rated on a 5-point Likert scale ranging from 1 ("strongly disagree") to 5 ("strongly agree"). Scores for closeness and conflict are calculated separately, with higher closeness scores indicating a stronger emotional bond and a supportive relationship between parents and children (Driscoll & Pianta, 2011). Higher conflict scores indicate greater conflict between parents and children. The internal consistency reliabilities were adequate in a Chinese sample (Cronbach's alpha = 0.78 to 0.81) (Tan et al., 2023).
Baseline (T0), Post-workshop assessment (T1, 2 weeks after T0), and 12-week assessment (T2, around 3 months after T0).
Parenting Competence
Prazo: Baseline (T0), Post-workshop assessment (T1, 2 weeks after T0), and 12-week assessment (T2, around 3 months after T0).
The Parenting Sense of Competence Scale (PSOC) (Ngai et al., 2007) is a 17-item scale to measure parents' perceived competence in the parenting role. Each item is rated on a 6-point Likert scale ranging from 1 (strongly disagree) to 6 (strongly agree). Higher scores indicate greater competence in parenting. Cronbach's alpha was 0.93 in a Chinese sample.
Baseline (T0), Post-workshop assessment (T1, 2 weeks after T0), and 12-week assessment (T2, around 3 months after T0).
Family function
Prazo: Baseline (T0), Post-workshop assessment (T1, 2 weeks after T0), and 12-week assessment (T2, around 3 months after T0).
The Family Communication Scale (FCS) is a 10-item scale used to measure family communication (Guo et al., 2021). Items are rated on a 5-point Likert scale, ranging from 1 ("strongly disagree") to 5 ("strongly agree"). A higher total score (range 10-50) indicates a higher level of positive family communication. The Chinese version of FCS showed good internal consistency (Cronbach's alpha = 0.91) and was stable over 1 month (intraclass correlation coefficient = 0.69).
Baseline (T0), Post-workshop assessment (T1, 2 weeks after T0), and 12-week assessment (T2, around 3 months after T0).
Anxiety
Prazo: Baseline (T0), Post-workshop assessment (T1, 2 weeks after T0), and 12-week assessment (T2, around 3 months after T0).
The Generalized Anxiety Disorder (GAD)-7 scale is a 7-item instrument to assess anxiety symptoms in the past two weeks (Spitzer et al., 2006; Tong et al., 2016). Each item is scored from 0 to 3. The seven item scores are summed to yield a total score ranging from 0 to 21, with higher scores indicating greater anxiety symptom severity.
Baseline (T0), Post-workshop assessment (T1, 2 weeks after T0), and 12-week assessment (T2, around 3 months after T0).

Outras medidas de resultado

Medida de resultado
Descrição da medida
Prazo
Perceived Benefits
Prazo: Post-workshop assessment (T1) and 12-week assessment (T2, around 3 months after T0)
Evaluated through process evaluation metrics assessing perceived benefits, subjective changes in personal mental health, and happiness. Participants rate overall satisfaction on a 0-10 scale, with 0 indicating "very dissatisfied" and 10 indicating "very satisfied". Open-ended questions will also collect participants' comments and suggestions.
Post-workshop assessment (T1) and 12-week assessment (T2, around 3 months after T0)

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Investigadores

  • Investigador principal: Yuying Sun, PhD, Hong Kong Metropolitan University

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Estimado)

1 de outubro de 2026

Conclusão Primária (Estimado)

30 de junho de 2027

Conclusão do estudo (Estimado)

30 de setembro de 2027

Datas de inscrição no estudo

Enviado pela primeira vez

14 de setembro de 2026

Enviado pela primeira vez que atendeu aos critérios de CQ

14 de setembro de 2026

Primeira postagem (Real)

17 de setembro de 2026

Atualizações de registro de estudo

Última Atualização Postada (Real)

17 de setembro de 2026

Última atualização enviada que atendeu aos critérios de controle de qualidade

14 de setembro de 2026

Última verificação

1 de setembro de 2026

Mais Informações

Termos relacionados a este estudo

Plano para dados de participantes individuais (IPD)

Planeja compartilhar dados de participantes individuais (IPD)?

NÃO

Descrição do plano IPD

We are not sharing individual participant data (IPD) due to privacy concerns and limitations in participant consent. Although the data is de-identified, there remains a risk of re-identification, and participants were not explicitly consented for public data sharing. Aggregate results will be made available through publications and presentations to ensure transparency.

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

Se inscrever